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Background: Coronally advanced flap (CAF) has been
shown to effectively treat gingival recession. Platelet-rich
plasma (PRP), containing autologous growth factors, has been
shown to promote soft tissue healing. Therefore, the purpose
of this study was to evaluate the effects of PRP in combination
with CAF.
Methods: Twenty-four systemically healthy patients par-
ticipated in this study. A singleMiller’s Class I buccal recession
defect per patient was treated. These patients were randomly
assigned into CAF or PRP + CAF groups. Clinical parameters
included recession depth (RD), recessionwidth (RW), gingival
thickness (GT), width of keratinized tissue (WKT), clinical at-
tachment level (CAL), probing depth (PD), plaque index (PI),
wound healing index (WHI), and gingival index (GI). PRP was
prepared fromwhole blood drawn prior to surgery and applied
to root surfaces. Patients were followed at 2, 4, 12, and 24
weeks post-surgery.
Results: Twenty-three patients completed the study. The
RD at 24 weeks was significantly reduced from 2.9 – 0.5 to
0.5 – 0.6 mm in the CAF group (P <0.05) and from 2.8 – 0.2
to 0.5 – 0.7 mm in the PRP + CAF group (P <0.05). The mean
root coverage was 83.5% – 21.8% in the CAF group and
81.0% – 28.7% in the CAF + PRP group (P >0.05). Fourteen
out of 23 patients (60.9%) experienced 100% root coverage
at the 24-week postoperative follow-up.
Conclusion: Based on the results of this pilot study, the ap-
plication of PRP in CAF root coverage procedure provides no
clinically measurable enhancements on the final therapeutic
outcomes of CAF in Miller’s Class I recession defects. J Peri-
odontol 2005;76:1768-1777.
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G
ingival recession is defined as the
gingival margin located apical to
the cemento-enamel junction
(CEJ).1 The prevalence of gingival re-
cession ranges from 20% to 100% in
adults.2-5 Gingival recession may result
in dentinal hypersensitivity,6 pain, dif-
ficult oral hygiene,7 root caries, un-
aesthetic gingival appearance, and
periodontal attachment loss.8 Therefore,
root coverage procedures have been
developed to treat these clinical condi-
tions. Modalities of root coverage pro-
cedures include 1) laterally sliding flap9;
2) double papillae flap10; 3) coronally
advanced flaps (CAF)11,12; 4) epithelial-
ized gingival graft13; 5) subepithelial
connective tissue graft14; and 6) guided
tissue regeneration (GTR)-based root
coverage procedures.15 Coronally repo-
sitioned flaps were originally used to gain
attachment on teeth with periodontal
disease.11 They were later modified to
repair gingival recession.16Thecoronally
repositioned flap is less technique sensi-
tive than rotational flaps. It also eli-
minates the need to harvest donor tissue
and minimizes the morbidity of donor
areas. The term ‘‘coronally advanced
flap’’ was coined by Pini-Prato et al.17 in
1999 to better reflect the procedure. CAF
has been shown to predictably achieve
root coverage. The average root cover-
age achieved with this technique ranges
from 75% to 82.7%, with 24% to 95% of
sites achieving complete root cover-
age.18,19 Histologically, CAF resulted
in the re-formation of epithelial and
* Currently, private practice, Taipei, Taiwan; previously, Department of Periodontics/
Prevention/Geriatrics, University of Michigan, School of Dentistry, Ann Arbor, MI.
† Department of Periodontics/Prevention/Geriatrics, University of Michigan, School of
Dentistry.
Volume 76 • Number 10
1768
connective tissue attachment with minimal bone
repair.20,21 Thereafter, various adjunctive agents
have been applied to promote healing and further
enhance clinical outcomes. These include root con-
ditioners (e.g., citric acid22,23 and tetracycline24),
enamel matrix proteins,25-28 recombinant human
growth factors, and platelet-rich plasma (PRP).29
PRP has become a focus of current studies due to its
potential to accelerate wound healing.30,31
PRP is derived from concentrated platelets, allow-
ing it to deliver a greater concentration of autologous
growth factors including platelet-derived growth
factor (PDGF), transforming growth factor beta
(TGF-b), vascular endothelial growth factor (VEGF),
insulin-likegrowth factor (IGF)-I,andepithelialgrowth
factor (EGF).32-37 These native growth factors pro-
mote fundamental phases of tissue repair such as mi-
togenesis and angiogenesis.38 Moreover, PRP can be
considered a safe method of growth factor utilization
due to its autologous origin. Depending on the initial
platelet counts, it is common to achieve platelet con-
centration three times higher than baseline.34,35,39-41
PRP was introduced to dentistry in 1998 by Marx
et al.34Marx stated that PRP should containmore than
1,000,000 platelets/ml to effectively enhance wound
healing.38 Many studies have demonstrated that
PRP is able to enhance early graft maturity, bone den-
sity, and new bone formation in ridge preservation
procedures,31,42 mandibular reconstruction,43 repair
of peri-implant defects,44-47 and sinus augmenta-
tion.48-52 Although these studies examining PRP and
its potential on bone healing showed encouraging re-
sults, limited evidence exists for its effects on soft tis-
sue healing. So far, to our knowledge, only one case
report has been published regarding the application
of PRP with subepithelial connective tissue grafts or
GTR root coverage procedures.29 It was found that
PRP decreased postoperative bleeding, enhanced soft
tissuehealing,promoted initial stabilizationandrevas-
cularization of the flaps and grafts, and reduced post-
operative infection and graft sloughage. Hence, the
purpose of this randomized, controlled pilot trial was




This study was designed as a randomized, controlled,
examiner-masked pilot clinical trial. The protocol was
reviewed and approved by the University of Michigan
Institutional Review Board (IRB). All subjects were re-
quired to read and sign an informed consent form ex-
plaining all study-related procedures before inclusion
in the study. Twenty-four subjects were randomly as-
signed to either test (PRP + CAF) or control groups
(CAF). Randomization was performed immediately
prior to surgery by drawing envelopes including notes
stating either ‘‘test’’ or ‘‘control.’’ Presurgical proce-
dures included oral hygiene instructions, full-mouth
scaling and root planing, and occlusal adjustment
as indicated. Surgical procedures as well as PRP prep-
arations were performed by a single investigator. A
masked and calibrated examiner collected and re-
corded the clinical parameters.
Subject Recruitment
From January 2, 2003 to February 28, 2004, 24 pa-
tients were recruited from the University of Michigan,
School of Dentistry based on the following inclusion
criteria: 1) systemically healthy subjects; 2) non-
smokers; 3) patients who were willing to comply with
all study-related procedures; 4) ‡18 years old; 5) abil-
ity to maintain good oral hygiene (O’Leary plaque
score53 £20%); 6) maxillary or mandibular incisors,
canines, or premolars with Miller’s Class I (confirmed
by radiographic analysis of the involved tooth) facial
gingival recession;54 7) gingival thickness (GT) ‡0.5
mm asmeasured 2 mm apical to the gingival margin;
8) width of keratinized gingiva ‡2 mm; and 9) reces-
sion depth (RD) ‡2 mm. The exclusion criteria was
determined as follows: 1) previous surgical attempt
to correct the gingival recession; 2) long-term (>2
weeks) use of antibiotics in the past 3 months; 3)
known allergies to thematerials used; 4) subjects with
compromised healing potential; 5) subjects with ac-
tive infectious diseases (hepatitis, tuberculosis, HIV,
etc.); 6) patients taking steroids or medications
known to cause gingival enlargement; and 7) preg-
nant or attempting to become pregnant.
Clinical Parameters
The following clinical parameters were collected and
recorded; all linear measurements were recorded
to the nearest 0.5 mm using a University of North
Carolina (UNC) probe: 1) probing depth (PD)
was measured at three points on the custom stent
(mesio-buccal, mid-buccal, and disto-buccal). The
measurement wasmade from the free gingivalmargin
to themost apical part of the sulcus; 2) clinical attach-
ment level (CAL)wasmeasured at the same reference
points used for PD. Themeasurement wasmade from
the CEJ to the most apical part of the sulcus; 3) width
of keratinized tissue (WKT) wasmeasured at the mid-
buccal point from themucogingival junction (MGJ) to
the free gingival margin by a Boley gauge caliper. The
MGJ was determined using the rollover technique; 4)
RDwasmeasured by a Boley gauge at themid-buccal
aspect of the tooth. The distance from the stent to the
most apical point of free gingival margin was sub-
tracted from the distance from the stent to the CEJ;
5) recession width (RW) was measured 1 mm apical
to the CEJ or crownmargin in amesio-distal direction
also using aBoley gauge caliper; 6)GTwasmeasured
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at the mid-buccal 2 mm apical to the free gingival
margin by penetrating a UNC probe into the tissue
and recorded to the nearest 0.5 mm; 7) plaque index
(PI) was recorded according to Silness and Löe55; 8)
gingival index (GI) was recorded according to Löe56;
9) wound healing index (WHI) was recorded after sur-
gery using the following criteria: score 1 = uneventful
healing with no gingival edema, erythema, suppura-
tion, patient discomfort, or flap dehiscence; score
2 = uneventful healing with slight gingival edema,
erythema, patient discomfort, or flap dehiscence,
but no suppuration; and score 3 = poor wound healing
with significant gingival edema, erythema, patient
discomfort, flap dehiscence, or any suppuration;
and10) the percentage of root coverage (RC)was cal-
culated as ([RD preoperation - RD postoperation]/RD
preoperation) · 100%.
Data Collection
Measuring stents for each surgical site were fabricated
from self-curing orthodontic acrylic resin. Clinically
reproducible measuring points were marked on
the stent at the mesio-buccal, mid-buccal, and disto-
buccal aspects as standardized reference points to
assess clinical parameters. Calibration for intraexa-
miner reliability was performed before, during, and
after the study. Two sites in two patients were used
for each calibration appointment. Two sets of mea-
surements for each site were recorded at different
times within the same day. The intermeasurement in-
terval was 2 hours. The mean kappa value for all pa-
rameters was 0.85 prestudy, 0.88 during the study,
and 0.90 post-study.
Surgical Protocol
All procedures were performed under local infiltration
of 2% lidocaine combined with 1:100,000 epineph-
rine. Sulcular incisions were used on the buccal as-
pect of the tooth. At papillary areas, the incisions
followed the outline of the papilla. The distance be-
tween the tip of the papillae and the papillary incision
was equivalent to the recession depth. Two vertical
releasing incisions were made at the line angles of
adjacent teeth and extended into the mucosa. Full-
thickness mucoperiosteal flaps were elevated. A re-
leasing incision through the periosteum at the inner
aspect of the flap was made to allow coronal flap ad-
vancement without tension. Deepithelialization was
performed at each papillae to provide a connective
tissue bed for flap adaptation. The exposed root sur-
face was thoroughly planed using periodontal cur-
ettes, high-speed fine carbide burs, and low-speed
fine diamond burs to obtain a smooth and hard sur-
face. Patients in the test group then received PRP over
the root surfaces while those in the control group re-
ceivedno further treatment. Flapswere then coronally
advanced to cover the exposed root and sutured with
a long-lasting suture material.‡ A double sling suture
was placed at each flap papillae to secure the flap co-
ronally. Interrupted tag sutures were placed at the
center of the papillae to facilitate closed adaptation
of the flap and underlying connective tissue. Oblique
interrupted sutures were placed 45 toward the coro-
nal direction at the vertical incisions to secure the flap
in its newposition (Figs. 1 and 2). Gentle pressurewas
applied at the surgical site with moistened gauze to
achieve hemostasis and a close adaptation of the flap
to the underlying surface. No surgical dressing mate-
rials were used.
PRP Preparation
Prior to surgery, 30 ml venous blood was drawn from
patients randomized to the test group. The blood was
then distributed into 10-ml sterilized disposable tubes
with 1.5 ml acid citrate dextrose, which functioned
as an anticoagulant. The tubes were placed into a
general-purpose centrifuge§ for PRP preparation.
The techniques used in this study followed the guide-
lines proposed by Gonshor.41 Briefly, after counter-
balancing the tubes, the first spin was at 1,300 rpm
for 10 minutes. The result was a separation of the
whole blood into blood cell and plasma layer. The
plasma layer and uppermost part of the cell layer
was drawn and placed into 10-ml sterilized tubes that
had no anticoagulant. The tubeswere then inserted in-
to the centrifuge for a second spin at 2,000 rpm for 10
minutes. The second spin separated PRP at the bot-
tom and clear straw-colored serum at the top. The se-
rum was removed. The PRP layer was then expressed
into a sterile container and prepared for use. The clot
initiator was a mixture of 5 ml 10% calcium chloride
(CaCl2) and 5,000 U bovine thrombin.
i The protocol
of PRP activation was adding CaCl2/thrombin in a
10:1 ratio. After a few seconds, the activated PRP gel
was applied to the test sites as a coating membrane.
Platelet Count
Platelet countingwas performed to compare the num-
ber of platelets in whole blood and PRP. Platelet levels
were determined by a hematology analyzer. Three
milliliters of whole blood was drawn in an anticoagu-
lant-coated tube. Due to the counting limitation of the
machine (1,000,000 platelets/ml), PRP samples re-
quired for a platelet countwere dilutedwith phosphate
buffered saline in a 1:9 ratio.
Postoperative Care
Analgesics (non-steroidal anti-inflammatory drugs
[NSAIDs]) were prescribed to control postoperative
discomfort. No antibiotics were prescribed. Patients
‡ 5.0 Vicryl, Ethicon, Johnson & Johnson, Somerville, NJ.
§ Maxm, ACE Surgical Supply, Brockton, MA.
i COULTER MAXM, Global Medical Instrumentation, Ramsey, MN.
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were informed not to brush or floss the surgical sites
for 3 to 4 weeks. Instead, they were informed to alter-
nate rinsing with salt water and 0.12% chlorhexidine
gluconate rinse for plaque control. Sutures were re-
moved 10 to 14 days after the surgery. Oral hygiene
instructions and professional cleaning were provided
at each follow-up visit when indicated.
Statistical Analysis
Data were reported as mean – standard deviation. A
statistical software program¶ was used for data anal-
ysis. The Wilcoxon signed rank test was used to ana-
lyze parameters before and after treatment within
each group. The Mann-Whitney test was used to ana-
lyze parameters between test and control groups. All
tests were two-sided, and differences were considered
statistically significant at P <0.05.
RESULTS
Demographics and Sites
Onepatient who had amandibular premolar site in the
test group dropped out of the study after the 1-month
follow-up. A total of 23 patients completed the study.
Themean age of these patients was 43.8 – 11.9 years
(24 to 63 years). The mean age in the CAF and PRP +
CAF groups was 40.8 – 11.5 years and 47.1 – 11.8
Figure 1.
Surgical procedures and results of PRP + CAF. A 26-year-old female patient showed a 2.5-mm recession defect at tooth #12. A) Initial presentation. B)
Incisions. C) PRP placed on the root surface.D) Graft is sutured. E) Two-week postoperative follow-up demonstrated WHI = 1. F) Six-month follow-up.
¶ SPSS 12, SPSS, Chicago, IL.
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years, respectively (P >0.05). There were 17 females
and six males. Nineteen maxillary (11 canines and
eight premolars) and four mandibular (two incisors
and two premolars) teeth were treated. There were
10 maxillary (six canines and four premolars) and
two mandibular (incisor) teeth in the CAF group. In
the PRP + CAF group, there were nine maxillary (five
canines and four premolars) and two mandibular
(premolar) teeth.
Baseline Measurements
The average initial RD on the control group was
2.9 – 0.5 mm (2.5 to 4 mm) and 2.8 – 0.2 mm
(2.5 to 3 mm) in the PRP + CAF group. The mean
RW of the CAF and PRP + CAF was 3.2 – 0.7 and
3.6 – 0.4 mm, respectively. The mean WKT of the
CAF and PRP + CAF was 2.7 – 1.2 and 2.7 – 1.4
mm. The average baseline GT of CAF and PRP +
CAF was 1.1 – 0.4 and 1.1 – 0.2 mm. None of these
baseline clinical parameters showed statistically sig-
nificant differences between the groups (P >0.05;
Table 1).
Platelet Count
The mean platelet count in whole blood was 235.3 –
38.6 · 103/ml (149 to 308 · 103/ml). Themean platelet
Figure 2.
Surgical procedures and results of CAF. A 24-year-old female patient showed a 2.8-mm recession defect at tooth #6. A) Initial presentation. B)
Incisions. C) Root surface preparation. D) Graft is sutured. E) Two-week postoperative follow-up demonstrated WHI = 1. F) Six-month follow-up.
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count in PRP was 4,085.8 – 2,420.6 · 103/ml (580 to
9,180 · 103/ml). The average increase of platelet con-
centration in PRP compared to whole blood was 17.5
times (2.5 to 40.6 times). The mean PRP production
per 10 ml whole blood was 0.3 ml. The mean platelet
recovery from whole blood was 57.9%.
Intragroup Comparisons
The reduction of RD and RW 6 months after surgery
was statistically significant compared to the baseline
(P <0.05) in both groups (Table 2). The gain of CAL
and RC was also significant at 3 and 6 months in both
groups (P <0.05). The corresponding root coverage
achieved to PRP concentration is presented in Table
3. The mean platelet number of PRP in cases associ-
ated with complete root coverage was 3,767.1 –
2,876.4 · 103/ml (580 to 9,180 · 103/ml). In the
CAF group, the 0.6 mm gain of WKT was significant
after 6months (P <0.05; Table 2). A 0.3-mm increase
of GT was observed in the CAF group after 6 months,
while the PRP + CAF group demonstrated a 0.6 mm
gain in GT (P <0.05; Table 2). The WHI at 2 weeks
was 1.3 – 0.5 in the CAF group and 1.2 – 0.4 in the
PRP + CAF group; both groups returned to 1 after 1
month. The GI at 2 weeks and 1 month after surgery
increased significantly in both groups but returned
to baseline after 3 months. PI increased 2 weeks after
the treatment and gradually returned to the baseline in
both groups. Themeasurements of PD remained con-
sistent throughout the study. There was an outlier, RC
20%, in the PRP + CAF group. The characteristics of
this case weremandibular first premolar, thin gingival
tissue(1mm),andshallowvestibule.Theplatelet con-
centration in this patient’s whole bloodwas 288 · 103/
ml and 5,884 · 103/ml in PRP, producing a 20.4 ratio.
Even though minimal root coverage was accom-
plished, theWKT increased to 2mm. No further treat-
ment was provided upon the patient’s request.
Intergroup Comparisons
At 3months, themean RC for CAF group was 88.1% –
16.9% (58.6% to 100%) and the PRP +CAF group was
81.8% – 27.7% (12% to 100%). At the 6-month follow-
up, themean RC of the CAF groupwas 83.5% – 21.8%
(48.3% to 100%) and the PRP +CAF group was 81.0%
– 28.7% (20% to 100%). After elimination of the outlier
in the PRP +CAF group, the RC at 3 and 6months was
88.8 – 16.1% (60% to 100%) and 87.1% – 21.4%
(44.4% to 100%), respectively. The comparisons of
RC between the groups showed no statistically signif-
icant difference (P >0.05). Overall, 14 out of 23 pa-
tients (60.9%) achieved complete root coverage.
Seven out of 12 patients (58.3%) in the CAF group
achieved 100% root coverage. For the PRP + CAF
group, seven out of 11 patients (63.6%) showed
100% root coverage. The RD at 6 months was 0.5 –
Table 1.






(n = 11) P Value*
RD (mm) 2.9 – 0.5 2.8 – 0.2 NS
RW (mm) 3.2 – 0.7 3.6 – 0.4 NS
WKT (mm) 2.7 – 1.2 2.7 – 1.4 NS
GT (mm) 1.1 – 0.4 1.1 – 0.2 NS
PD (mm) Mesio-buccal 2.8 – 0.6 2.5 – 0.5 NS
Mid-buccal 1.8 – 0.9 1.6 – 0.7 NS
Disto-buccal 2.7 – 0.8 2.7 – 0.5 NS
CAL (mm) Mesio-buccal 1.7 – 0.5 1.8 – 0.7 NS
Mid-buccal 4.7 – 0.8 4.3 – 0.7 NS
Disto-buccal 1.8 – 0.6 1.9 – 1.0 NS
PI Mesio-buccal 0.6 – 0.9 0.5 – 0.7 NS
Mid-buccal 0.8 – 0.9 0.9 – 0.8 NS
Disto-buccal 1.0 – 0.9 0.8 – 0.6 NS
GI Mesio-buccal 0.3 – 0.6 0.3 – 0.7 NS
Mid-buccal 0.7 – 0.7 0.8 – 0.8 NS
Disto-buccal 0.4 – 0.8 0.4 – 0.7 NS
* P value based on the Mann-Whitney test.
NS = not statistically significant.
Table 2.
Intragroup Comparisons
Variables Groups Mean – SD P Value*
RC (%) CAF 83.5 – 21.8 0.002
†
PRP + CAF 81.0 – 28.7 0.003†
RD (mm) CAF -2.5 – 0.8 0.002†
PRP + CAF -2.3 – 0.9 0.003†
RW (mm) CAF -2.9 – 1.0 0.002†
PRP + CAF -3.1 – 1.0 0.003†
CAL (B) (mm) CAF -3.0 – 1.4 0.002†
PRP + CAF -2.5 – 1.4 0.003†
WKT (mm) CAF 0.6 – 0.7 0.025†
PRP + CAF 0.3 – 0.9 NS
GT (mm) CAF 0.3 – 0.4 NS
PRP + CAF 0.6 – 0.4 0.007†
* P value was based on the Wilcoxon signed rank test.
† Statistical significance between baseline and 6 months (P <0.05).
NS = not statistically significant.
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0.6mm in the CAF group and 0.5 – 0.7mm in the PRP
+CAFgroup (P >0.05).Without the outlier in the PRP +
CAF group, the RD decreased to 0.4 – 0.6 mm, still
showing no differences between the groups. Other
clinical parameters, such as RW, WKT, GT, PD,
CAL, PI, and WHI, also showed insignificant differen-
ces between the groups (Table 4).
DISCUSSION
PRP has been shown to enhance soft tissue healing,
promote initial stabilization, and revascularization of
the flaps and grafts in root coverage procedures.29
However, limited evidence is currently available veri-
fying these claims. Therefore, this pilot study was
designed to investigate the effects of PRP on CAF root
coverage procedure.
The technique to produce PRP was introduced by
Gonshor.41 According to this report, the technique
is able to produce a platelet concentration eight times
greater than whole blood. The volume of PRP pro-
duced was 0.85 ml from 8.5 ml blood, and the mean
platelet recovery was 67.5%. The concentration of
TGF-b1 and PDGF-AB in PRP was, respectively,
14.5 and 11 times more than the whole blood.41 In
our study, the average increase of platelet concentra-
tion in PRP was 17.5 times (2.5 to 40.6 times) com-
pared to baseline. The only sample that showed less
than 1,000 · 103/ml platelets was the very first one,
suggesting that this technique is sensitive and re-
quires a learning curve. The average PRP production
per 10mlwhole bloodwas 0.3ml. This was lower than
the previous report. However, this small volume of
PRP contributed to the increased platelet concentra-
tion comparing to other studies.34,41 The mean plate-
let recovery from whole blood was 57.9%, which was
lower than Gonshor’s result. This might be explained
by the small volume of PRP procured from whole
blood. Recent advances in PRP technology are able to
provide more consistent platelet concentrations than
those observed in this study. However, despite the
small sample size observed, no dose-dependent effect
of PRP on soft tissue wound healing could be detected.
No statistically significant differences were noted
between groups, suggesting that both procedures
are comparable to treat Miller’s Class I recession de-
fects. The mean RC at 6 months was 83.5% – 21.8%
in CAF and 81.0% – 28.7% in PRP + CAF. Complete
root coverage was achieved in 58.3% of CAF treated
sites and 63.6% of PRP +CAF sites. These results were
in agreement with others.17,57-59 Results from these
studies indicated that CAF is a predictable root cover-
age procedure. The application of PRP showed no ad-
ditional benefit to enhance outcomes achieved by
CAF alone. Thismay be partly due to the favorable re-
Table 3.
Correlation Between Platelet Concentration







(103/ml) Ratio % RC Tooth #
1 226 9,180 40.6 100 6
2 256 3,070 12.0 100 6
3 215 3,280 15.3 100 11
4 224 1,060 4.7 100 11
5 232 580 2.5 100 11
6 272 4,500 16.5 60 12
7 220 6,640 30.2 66.7 12
8 216 3,990 18.5 100 12
9 248 5,210 21.0 100 12
10 308 3,520 11.4 44.4 20
11 257 5,880 22.9 20 28
Table 4.
Intergroup Comparisons
Parameters CAF PRP + CAF P Value*


















WKT (mm) 6 months 3.2 – 1.0 3.1 – 0.7 NS
GT (mm) 6 months 1.4 – 0.4 1.7 – 0.5 NS
WHI 2 weeks 1.3 – 0.5 1.2 – 0.4 NS
GI (mesio-buccal)
3 months
0.8 – 0.6 0.2 – 0.4 0.044†
Data are presented as mean – standard deviation.
* P value based on the non-parametric Mann-Whitney test.
† Statistical significance between test and control groups (P <0.05).
NS = not statistically significant.
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sults obtained in both groups, small sample size, and
defects (Miller’s Class I) known to experience predict-
able root coverage. Future investigations including
larger sample sizes and more challenging recession
defects should be considered.
The effects of PRP on early soft tissue healing were
analyzed by clinical evaluation. The indices usedwere
GI andWHI,whichwere developed to evaluate the gin-
gival appearance (i.e., erythema and edema). The
PRP + CAF group had a lower WHI 2 weeks after sur-
gery than CAF alone. However, because of the small
sample size, the difference was not statistically signif-
icant. Nonetheless, the WHI reached a plateau 1
month after surgery in both groups suggesting un-
eventful healing regardless of the PRP application.
PDGF and VEGF, the main autologous growth factors
of PRP, are associatedwith pericytes and capillary for-
mation, respectively, and serve as potent angiogenic
factors.60-62 These growth factors might enhance soft
tissue healing by increasing the angiogenesis andma-
trix biosynthesis during early wound healing. A recent
report in an ex vivo model of gingival repair showed
that sustained PDGF delivery promotes wound clo-
sure.63 The results from this study showed the trend
of accelerated soft tissue healing in the PRP group,
which was confirmed by clinical visual investigation.
However, this short-term benefit did not influence
the final clinical outcomes, e.g., percentage of root
coverage. In addition, PDGF, TGF-b, and IGF-I found
in PRP have been demonstrated to regenerate new
bone and cementum.64-67 Histological studies have
demonstrated that the dentogingival junction after
CAF surgery was established by reformation of epi-
thelial and connective tissue attachment withminimal
bone repair.20,21 Nevertheless, no histological exam-
ination was performed in the present study. Hence,
the effect of PRP on the overall regeneration capacity
remains to be determined. Further studies in this field
are needed.
Six months after surgery, the PRP + CAF group
gained 0.4mmGT above that of CAF alone. Although
this increase was not statistically significant (P = 0.1),
based on our data, if the sample size was increased to
27 subjects in each group, we would be able to detect
a 0.35-mm difference between the groups at a = 0.05
with 80% power.
The threshold of platelet concentration and its cor-
relation to RCwas difficult to designate in this study. In
the PRP +CAF group, themean platelet concentration
of PRP in those achieving 100% root coverage was
3,767.1 – 2,876.4 · 103/ml with a wide range from
580 to 9,180 · 103/ml. In cases that did not achieve
complete root coverage, the average platelet concen-
tration of PRP was higher (5,135.0 – 1,394.2 · 103/
ml). The platelet concentrations in PRP have been
shown to have individual variability.40,41 Preparation
techniques also contribute to the variation.40 How-
ever, patient age and gender do not appear to be cru-
cial factors.35,39 Recently, one animal study found
that the platelet concentration in PRP was important
to determine its biological effect. With intermediate
platelet concentration, approximately 1,000 · 103/
ml, more bone regeneration was observed.68
Although growth factor levels of PRP were not mea-
sured in this study, previous reports failed to show that
the growth factor content correlated with the platelet
concentration in the whole blood and the PRP.35,41
Hence, there is no strong evidence to support the re-
lationship between the platelet concentration and
wound healing enhancement. Despite the small sam-
ple size in this study, no dose-response relationship
was observed betweenplatelet concentration and root
coverage.
This pilot study indicates that CAF is a predictable
approach to treat Miller’s Class I gingival recession.
The additional application of PRP failed to improve
root coverage after CAF in Miller’s Class I recession
defects. However, a positive trend of PRP utilization
was observed since lower GI and WHI values as well
as increasedGT postoperatively were observed in this
group. It is important to emphasize that this positive
trend should be better observed and confirmed in
studies involving a larger number of subjects. The lack
of difference between groups could also lead to differ-
ent outcomes in a larger sample size. Therefore, future
studies with larger sample sizes are recommended to
further explore this hypothesis.
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